All participants in the Phase 3 clinical trial of Taiwan-based Medigen Vaccine Biologics Corp.'s COVID-19 vaccine in Paraguay have now received two shots of either the Medigen or AstraZeneca vaccine, the company said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Legislative Yuan passes law amendments to increase fraud penalties
12/30/2025 03:22 PM - Society
Taiwan recorded 138,051 new cancer cases in 2023: Health agency
12/30/2025 02:26 PM - Business
Taiwan shares close down 0.36%
12/30/2025 02:11 PM - Cross-Strait
Lai says China's drills 'not behavior of a responsible world power'
12/30/2025 01:58 PM - Cross-Strait
90 PLA warplanes cross Taiwan Strait median line as China stages drills
12/30/2025 12:46 PM